Tevogen Bio Holdings Inc. (TVGN) NASDAQ

1.47

+0.01(+0.68%)

Updated at February 04 04:00PM

Currency In USD

Valuation

Market Cap1.84B
Enterprise Value1.84B
P/E Ratio-48.94
PEG Ratio0.94
Price/Sales Ratio0
Price/Book Ratio-40.41
Enterprise/Revenue0
Enterprise/EBITDA-78.03

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.19
Return On Equity1.01

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA188,706
Net Income-67,325
Diluted EPS-0

Balance Sheet

Total Cash2.33M
Total Cash/Share0.01
Total Debt2.96M
Total Debt/Equity-0.48
Current Ratio0.34
Book Value Per Share-0.04

Price History

52-Week Change-72.21
52-Week High21.09
52-Week Low0.26
Moving Average 50 Days1.23
Moving Average 200 Days1

Statistics

Average Volume3.54M
Shares Outstanding175.05M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A